Sponsor or institution

Clinical trials and research at Allarity Therapeutics

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• 2X-121 treatment for recurrent advanced ovarian cancer

  This study will test whether two dose schedules of the experimental drug 2X-121 (600 mg or 800 mg daily, split twice daily) are safe and effective for people with recurrent advanced ovarian cancer that is platinum‑resistant or platinum‑ineligible.

  Recruiting at 2 sites Phase 2 Allarity Therapeutics · Oklahoma City, Oklahoma and 1 other locations · NCT03878849

• Pre-screening to match ovarian cancer tumor samples with investigational cancer drugs

  Tests if analyzing archived tumor tissue with a Drug Response Predictor can show which ovarian cancer patients might benefit from certain investigational cancer drugs.

  Recruiting at 9 sites Allarity Therapeutics · Tampa, Florida and 8 other locations · NCT03877796

Quick answers

How many clinical trials run by Allarity Therapeutics are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →